About this trial
The aim of the registry is to investigate the effect of catheter-assisted procedures in the context of structural heart disease on clinical morbidity and mortality. Furthermore, the long-term prognosis of patients after a catheter-based procedure is to be evaluated.
In particular, the following parameters will be documented and the following questions discussed:
* Underlying and concomitant diseases of these patients * Evaluation of the methods in relation to the respective disease * Safety - acute and long-term * Effectiveness - periprocedural, hospital and long-term course * Concomitant therapies
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Structural heart disease
Disqualifiers
Patients without consent/information
Age ≤ 18 years
Trial population
All patients for who the indication for a catheter-based heart valve replacement or closure system was set due to a structural heart disease can be included.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Combined endpoint
Combined endpoint of NYHA classification, re-hospitalization, death, repeat procedure, heart transplantation, LVAD implantation (the order is not relevant) by day 30.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Prof. Dr. med. Ingo Eitel
Lead sponsor
University of Luebeck
Sponsor institution